CpG Island Hypermethylation of Cell-Free Circulating Serum DNA in Patients With Testicular Cancer

Journal of Urology

Volumn 182, Issue 1, 2009, Pages 324-329

  Ellinger, Jörg ^a   Albers, Peter ^a   Perabo, Frank G ^a   Müller, Stefan C ^a   von Ruecker, Alexander ^a   Bastian, Patrick J ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

methylation islands; seminoma; serum; testicular neoplasms; testis

Indexed keywords

APC PROTEIN; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; ENDONUCLEASE; GLUTATHIONE TRANSFERASE P1; PROSTAGLANDIN SYNTHASE; PROTEIN P14; PTGS2 ENZYME; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARCINOGENESIS; CELL FREE SYSTEM; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEMINOMA; SERODIAGNOSIS;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CPG ISLANDS; DNA; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; PROBABILITY; PROGNOSIS; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 66749190952     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.02.106     Document Type: Article

References (20)

1. Huyghe E., Matsuda T., and Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 170 (2003) 5
2. Albers P., Albrecht W., Algaba F., Bokemeyer C., Cohn-Cedermark G., Horwich A., et al. Guidelines on testicular cancer. Eur Urol 48 (2005) 885
3. Trigo J.M., Tabernero J.M., Paz-Ares L., Garcia-Llano J.L., Mora J., Lianes P., et al. Tumor markers at the time of recurrence in patients with germ cell tumors. Cancer 88 (2000) 162
4. Chaubert P., Guillou L., Kurt A.M., Bertholet M.M., Metthez G., Leisinger H.J., et al. Frequent p16INK4 (MTS1) gene inactivation in testicular germ cell tumors. Am J Pathol 151 (1997) 859
5. Honorio S., Agathanggelou A., Wernert N., Rothe M., Maher E.R., and Latif F. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours. Oncogene 22 (2003) 461
6. Kempkensteffen C., Christoph F., Weikert S., Krause H., Kollermann J., Schostak M., et al. Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors. J Cancer Res Clin Oncol 132 (2006) 765
7. Koul S., McKiernan J.M., Narayan G., Houldsworth J., Bacik J., Dobrzynski D.L., et al. Role of promoter hypermethylation in cisplatin treatment response of male germ cell tumors. Mol Cancer 3 (2004) 16
8. Lind G.E., Skotheim R.I., and Lothe R.A. The epigenome of testicular germ cell tumors. APMIS 115 (2007) 1147
9. Manton K.J., Douglas M.L., Netzel-Arnett S., Fitzpatrick D.R., Nicol D.L., Boyd A.W., et al. Hypermethylation of the 5′ CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis. Br J Cancer 92 (2005) 760
10. Smith-Sorensen B., Lind G.E., Skotheim R.I., Fossa S.D., Fodstad O., Stenwig A.E., et al. Frequent promoter hypermethylation of the O6-methylguanine-DNA methyltransferase (MGMT) gene in testicular cancer. Oncogene 21 (2002) 8878
11. Smiraglia D.J., Szymanska J., Kraggerud S.M., Lothe R.A., Peltomaki P., and Plass C. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene 21 (2002) 3909
12. Kawakami T., Okamoto K., Kataoka A., Koizumi S., Iwaki H., Sugihara H., et al. Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas. Genes Chromosomes Cancer 38 (2003) 97
13. Bastian P.J., Palapattu G.S., Lin X., Yegnasubramanian S., Mangold L.A., Trock B., et al. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Clin Cancer Res 11 (2005) 4037
14. Jahr S., Hentze H., Englisch S., Hardt D., Fackelmayer F.O., Hesch R.D., et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61 (2001) 1659
15. Ellinger J., El Kassem N., Heukamp L.C., Mathews S., Cubukluoz F., Kahl P., et al. Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer. J Urol 179 (2008) 346
16. Ellinger J., Bastian P.J., Haan K.I., Heukamp L.C., Buettner R., Fimmers R., et al. Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators. Int J Cancer 122 (2008) 138
17. Hoque M.O., Feng Q., Toure P., Dem A., Critchlow C.W., Hawes S.E., et al. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol 24 (2006) 4262
18. Ellinger J., Wittkamp V., Albers P., Perabo F.G., Muller S.C., von Ruecker A., et al. Cell-free circulating DNA: diagnostic and prognostic value in patients with testicular germ cell cancer. J Urol 181 (2009) 363
19. Lind G.E., Skotheim R.I., Fraga M.F., Abeler V.M., Esteller M., and Lothe R.A. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). J Pathol 210 (2006) 441
20. Koul S., Houldsworth J., Mansukhani M.M., Donadio A., McKiernan J.M., Reuter V.E., et al. Characteristic promoter hypermethylation signatures in male germ cell tumors. Mol Cancer 1 (2002) 8